Call us now0755-8668-0658 E-mailinfo@immuclin.com

Advantages

Advantages
Unique

Tumor-specific
strategy

Comprehensive
service

Quality
assurance

Intellectual property:ACTL is a patented technology of Immuclin

Group of experts in oncology, immunology and virology ensures constant development of ACTL technology.

Tumor-targeted - High efficacy in recognizing and destroying cancer cells.

Toxicity free - pailess treatment with no side effects

Intergrative therapy - possible to work together with other treatments

Shortened duration for cell processing

Service networks across China, Asia and USA.

Exclusive partnership in appointed region with full support.

ACTL技术的生产不仅操作简便,而且符合标准化、产业化、大规模生产的条件。

Procedures

Inquiry
Communication
Agreement
Signing Contract

Application

  • Upload
  • Upload